It has been demonstrated that IGF2BP2 promotes cancer progression by regulating the m6A-dependent glycolytic process and promotes cancer metastasis in the form of an RNA-protein ternary complex (Chen et al., 2019e). Here, IGF2BP2 is linked to cancer.